CSI Market
Sign In | Register

Adc Therapeutics Sa (ADCT) Annual Balance Sheets

Annual · GAAP · USD millions
Access ADCT quarterly Balance Sheets →
Examining balance sheet movements between Adc Therapeutics Sa and Dec 31 2021 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent261.34
Cash And Cash Equivalents0.00
Cash & Short-term Investments261.00
Accounts receivable29.12
Trade & Other Current Receivables (IFRS combined total)-
Notes Receivable, Current0.00
Inventories0.10
Other current assets6.08
Prepaid Expense And Other Assets Current5.61
Total Current Assets306.34
Equipment/Property/Plant Net1.38
Intangible Assets0.00
Long-term investments0.00
Income Taxes251.76
Other Assets16.82
Other Current Assets-
Trade And Other Current Receivables-
Rightofuse Assets-
Intangible Assets Other Than Goodwill-
Investments In Joint Ventures Accounted For Using Equity Method-
Noncurrent Assets-
Total Assets323.15
Liabilities
Accounts Payable, Current AC9.18
Accrued Liabilities, Current AC13.26
Long-term Debt, Current Maturities LO3.00
Other current liabilities0.00
Income & other taxes6.80
Total Current Liabilities70.16
Long-term debt115.50
Secured Debt115.50
Total Long-term Debt115.50
Pension & postretirement benefits2.16
Deferred income taxes0.79
Other longterm liabilities326.37
Operating Lease Liability Current-
Noncurrent Derivative Financial Liabilities-
Contingent Liabilities Incurred By Venturer In Relation To Interests In Joint Ventures-
Noncurrent Lease Liabilities-
Noncurrent Recognised Liabilities Defined Benefit Plan-
Operating Lease Liability Noncurrent1.03
Total Liabilities508.98
Stockholders' Equity
Common Stock Value11.08
Treasury Stock Value0.21
Additional Paid In Capital Common Stock1,439.75
Retained Earnings / Accumulated Deficit-1,635.94
Accumulated Other Comprehensive Income-0.52
Defined Benefit Plan and Other0.00
Other Equity-0.52
Common Stockholder's Equity-185.83
Total Stockholder's Equity-185.83
Liabilities & Stockholder's Equity323.15
4 historic quarters locked

Sign in to unlock the full Adc Therapeutics Sa balance sheet history.

Sign In Create Free Account

About Adc Therapeutics Sa Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 10, 2026
  • Source: adc-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-016491

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License